Pages that link to "Q52687792"

The following pages link to Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials. (Q52687792):

Displaying 16 items.

• Potent Acid Suppression with PPIs and P-CABs: What's New? (Q58554812) (← links)
• Helicobacter pylori Infection: New Facts in Clinical Management (Q58555850) (← links)
• PPIs for prevention and treatment of peptic ulcer (Q87864494) (← links)
• Systematic Analysis of Monoterpenes: Advances and Challenges in the Treatment of Peptic Ulcer Diseases (Q89682811) (← links)
• Physicians' Perceptions of Proton Pump Inhibitor Risks and Recommendations to Discontinue: A National Survey (Q89855510) (← links)
• Sustained proton pump inhibitor deprescribing among dyspeptic patients in general practice: a return to self-management through a programme of education and alginate rescue therapy. A prospective interventional study (Q90457613) (← links)
• Aspirin for primary prevention: Is this the end of the road? (Q91684219) (← links)
• Country-wide medical records infer increased allergy risk of gastric acid inhibition (Q92296189) (← links)
• Estimates of all cause mortality and cause specific mortality associated with proton pump inhibitors among US veterans: cohort study (Q92417285) (← links)
• Role of aspirin in primary prevention of cardiovascular disease (Q93053735) (← links)
• Aspirin, cancer, and bleeding: an equation to solve (Q93062766) (← links)
• Cardiovascular effects and safety of (non-aspirin) NSAIDs (Q93164270) (← links)
• Pumpkin Oil-Based Nanostructured Lipid Carrier System for Antiulcer Effect in NSAID-Induced Gastric Ulcer Model in Rats (Q94452892) (← links)
• Effects of aspirin on the gastrointestinal tract: Pros vs. cons (Q98386381) (← links)
• Aspirin for Primary Prevention of Cardiovascular Disease (Q98613620) (← links)
• Ethanolic extract of okra has a potential gastroprotective effect on acute gastric lesions in Sprague Dawley rats (Q104461503) (← links)